{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:42Z","timestamp":1791357282854,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012184","name":"Hersh Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jpsychires.2019.03.013","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T00:28:10Z","timestamp":1553041690000},"page":"165-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-1110","authenticated-orcid":false,"given":"Manish K.","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu","family":"Minhajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherise","family":"Chin-Fatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy L.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2019.03.013_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tins.2012.12.010","article-title":"Neuronal plasticity and antidepressant actions","volume":"36","author":"Castren","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2016.10.046","article-title":"Lack of association between depression and C-reactive protein level in the baseline of Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"208","author":"De Menezes","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0042-103159","article-title":"Modulatory effects of antidepressant classes on the innate and adaptive immune system in depression","volume":"49","author":"Eyre","year":"2016","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib5","article-title":"What does plasma CRP tell us about peripheral and central inflammation in depression?","author":"Felger","year":"2018","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib6","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Clinical Trials Version (SCID-CT) New York: Biometrics Research","author":"First","year":"2007"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbi.2010.09.013","article-title":"Anti-depressant medication use and C-reactive protein: results from two population-based studies","volume":"25","author":"Hamer","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","article-title":"Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder","volume":"95","author":"Haroon","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1017\/S0033291712000128","article-title":"Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis","volume":"42","author":"Hiles","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL- 1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.05.017","article-title":"Association of T and non-T cell cytokines with anhedonia: role of gender differences","volume":"95","author":"Jha","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2005.04.051","article-title":"Race and gender differences in C-reactive protein levels","volume":"46","author":"Khera","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbi.2017.02.020","article-title":"Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression","volume":"62","author":"K\u00f6hler-Forsberg","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib17","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm.4386","article-title":"Sex-specific transcriptional signatures in human depression","volume":"23","author":"Labont","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psychres.2014.05.025","article-title":"Association between C-reactive protein and depression: modulated by gender and mediated by body weight","volume":"219","author":"Liu","year":"2014","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2004.09.008","article-title":"Gender differences in depression: findings from the STAR*D study","volume":"87","author":"Marcus","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.comppsych.2007.06.012","article-title":"Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study","volume":"49","author":"Marcus","year":"2008","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157015912800604542","article-title":"Immunomodulation mechanism of antidepressants: interactions between serotonin\/norepinephrine balance and Th1\/Th2 balance","volume":"10","author":"Martino","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2265.2010.03879.x","article-title":"Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 Diabetes","volume":"74","author":"Mehta","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psyneuen.2017.04.006","article-title":"Is C-reactive protein ready for prime time in the selection of antidepressant medications?","volume":"84","author":"Miller","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib25","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1002\/oby.20135","article-title":"Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults","volume":"21","author":"Neeland","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1192\/bjp.bp.105.011015","article-title":"Antidepressant therapy and C-reactive protein levels","volume":"188","author":"O'Brien","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib27","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archgenpsychiatry.2009.81","article-title":"National patterns in antidepressant medication treatment","volume":"66","author":"Olfson","year":"2009","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.conctc.2017.02.007","article-title":"Statistical analysis plan for stage 1 EMBARC (establishing moderators and biosignatures of antidepressant response for clinical care) study","volume":"6","author":"Petkova","year":"2017","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.psyneuen.2017.02.035","article-title":"Depression and anxiety both associate with serum level of hs-CRP: a gender-stratified analysis in a population-based study","volume":"81","author":"Tayefi","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2010.12.007","article-title":"Reliability of the Hamilton rating scale for depression: a meta-analysis over a period of 49 years","volume":"189","author":"Trajkovi\u0107","year":"2011","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpsychires.2016.03.001","article-title":"Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): rationale and design","volume":"78","author":"Trivedi","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","article-title":"Increased serum tumor necrosis factor- alpha levels and treatment response in major depressive disorder","volume":"170","author":"Tuglu","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib35","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib36","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/01.CCM.0000266534.14262.E8","article-title":"Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers*","volume":"35","author":"Van Eijk","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib37","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1038\/ijo.2013.95","article-title":"Gender differences in the relationship between symptoms of depression and high-sensitivity CRP","volume":"37","author":"Vetter","year":"2013","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.jpsychires.2019.03.013_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73\u00e1131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA psychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.biopsych.2013.10.009","article-title":"Elevated C-reactive protein, depression, somatic diseases, and all-cause mortality: a mendelian randomization study","volume":"76","author":"Wium-Andersen","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.03.013_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychires.2008.07.002","article-title":"Sex differences in response to citalopram: a STAR\u2217D report","volume":"43","author":"Young","year":"2009","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619300226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619300226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:13:53Z","timestamp":1758366833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619300226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"alternative-id":["S0022395619300226"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.03.013","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}